3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
59
Neoplasm Metastasis
5
Prostate Cancer Metastatic
3
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
3
Adenocarcinoma
3
Prostate CA
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Metastatic Hormone-sensitive Prostate Cancer
2
Metastatic Castration-resistant Prostate Cancer
2
Urologic Diseases
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage IV Prostate Adenocarcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Recurrence
1
Radiation Injuries
1
Prostatic Diseases
1
PSA Level Greater Than 0.03
1
Oligometastatic Prostate Cancer
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Metastatic Hormone-Sensitive Prostate Cance
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castrate-sensitive Prostate Cancer
1
Lymphatic Metastasis
1
Intraprostatic Prostate Cancer
1
Hormone Sensitive Prostate Cancer
1
Genital Neoplasms, Male
1
Gastrointestinal Diseases
1
Interventions
Tadalafil
1
Surveys and Questionnaires
1
Saline Solution
1
Holistic Health
1
Educational Status
1
Cell- and Tissue-Based Therapy
1
Androgen Antagonists
1
Ambulatory Care Facilities
1
4-Aminopyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Erectile Dysfunction
×
Androgen Antagonists
×
1 year
×
Clear all
NCT07460726
2026-03-10
PRIAPUS-PCa
CancerCare Manitoba
Not yet recruiting
130 enrolled